Hyprogel0.3%

Hyprogel 0.3% is an ophthalmic lubricant (artificial tear substitute) used to relieve eye dryness and irritation. Indications can be classified as follows:

Established / Primary Use

• Dry eye syndrome (keratoconjunctivitis sicca): Hyprogel 0.3% is used for the temporary relief of burning, irritation, and discomfort due to dryness of the eye caused by deficient tear production or impaired lacrimal secretion.
• Exposure-related eye irritation: Hyprogel 0.3% is used to relieve minor eye irritation caused by exposure to wind, sun, or dry indoor/air-conditioned environments.

Guideline-Supported / Adjunct Uses

• Incomplete eyelid closure (lagophthalmos): Hyprogel 0.3% gel is used as a lubricant to protect the ocular surface when the eyelids do not close completely, such as during sleep or in certain neurological conditions.
• Contact lens comfort: Hyprogel 0.3% may be used as a lubricant before, during, or after contact lens wear (only with lens-compatible formulations) to reduce dryness-related discomfort.
• As a diagnostic/procedural aid: Used to maintain corneal moisture during ophthalmic examinations or minor procedures.

Other Pharmaceutical Uses

• Hyprogel 0.3% is also widely used as an inactive excipient (viscosity-modifying agent, tablet coating agent, or vehicle) in other pharmaceutical products, though this generic listing refers to its use as an ophthalmic lubricant, which is how it is primarily marketed in Bangladesh.

Hyprogel 0.3% ophthalmic products contain Hyprogel 0.3% (also known as hydroxypropyl methylcellulose, HPMC), a semisynthetic, water-soluble cellulose derivative, as the active ingredient.

• Ophthalmic Solution: Hyprogel 0.3% 0.3% w/v or 0.5% w/v
• Ophthalmic Gel: Hyprogel 0.3% 0.3% w/v
• Single-dose (preservative-free) container: Hyprogel 0.3% 0.5% w/v

Multi-dose formulations typically contain a preservative (commonly benzalkonium chloride) along with tonicity agents and buffers; single-dose units are usually preservative-free.

Hyprogel 0.3% is a semisynthetic, inert, viscoelastic cellulose polymer used topically in the eye as an artificial tear substitute and ocular lubricant. It is not a pharmacologically active drug in the traditional sense; rather, it acts as a demulcent that coats and lubricates the ocular surface.

Hyprogel 0.3% increases the viscosity of the tear film, which helps the film adhere longer to the surface of the eye, reducing irritation associated with dryness. It is one of the most commonly used ingredients in over-the-counter and prescription artificial tear products worldwide, and is marketed in Bangladesh in solution, gel, and single-dose formulations under several brand names.

Ophthalmic Lubricant / Artificial Tear Substitute (Ocular Demulcent)

Hyprogel 0.3% is a semisynthetic derivative of cellulose that functions as a viscosity-enhancing, film-forming ocular lubricant rather than as a pharmacologically active systemic agent.

Mechanism of Action

• Hyprogel 0.3% increases the viscosity and stability of the tear film covering the cornea and conjunctiva.
• It prolongs the residence (contact) time of the tear film on the ocular surface, reducing evaporation and friction during blinking.
• It coats and lubricates the corneal and conjunctival epithelium, protecting these surfaces from further desiccation and mechanical irritation.

Pharmacokinetics

Hyprogel 0.3% is applied topically to the eye and has negligible systemic absorption. It is not appreciably metabolized and produces no known systemic pharmacologic effect; its action is entirely local and physical/mechanical in nature.

Hyprogel 0.3% is for topical ophthalmic (eye) use only and must not be injected or taken orally.

• Wash hands thoroughly before instilling Hyprogel 0.3%.
• Tilt the head backward, look upward, and gently pull down the lower eyelid to create a small pouch.
• Instill the prescribed number of drops into the pouch, avoiding contact between the dropper tip and the eye, eyelid, fingers, or any surface to prevent contamination.
• Close the eye gently for a minute or two and, if possible, apply light pressure at the inner corner of the eye to reduce systemic drainage.
• If using more than one eye product, space applications at least 5–10 minutes apart, and instill the least viscous formulation first.
• Remove contact lenses prior to use unless the product is specifically labeled as suitable for use while wearing lenses.

Because Hyprogel 0.3% is applied topically to the eye and has negligible systemic absorption, clinically significant systemic drug interactions are not expected.

• Other ophthalmic products: When Hyprogel 0.3% is used together with other eye drops or ointments, applications should be spaced at least 5–10 minutes apart to prevent one product from washing out or diluting the other; generally instill less viscous drops before more viscous gels or ointments.
• Preservative-containing products: Frequent concurrent use of multiple benzalkonium-chloride-preserved eye products may increase the risk of ocular surface irritation; preservative-free single-dose Hyprogel 0.3% may be preferred for patients using multiple eye medications or with sensitive eyes.

Hyprogel 0.3% is generally very well tolerated because it is a topical, minimally-absorbed ocular lubricant. Reported side effects include:

Common

• Temporary blurred vision immediately after instillation
• Mild, transient stinging or burning sensation

Less Common

• Eye irritation or discomfort
• Watering (excess tearing) of the eye
• Redness of the eye

Rare

• Allergic/hypersensitivity reactions (eyelid swelling, itching, rash) — see Contraindications

Patients should seek medical evaluation if any side effect is severe, persistent, or associated with eye pain or vision changes (see Precautions and Warnings).

There are no well-controlled studies specifically establishing the safety of Hyprogel 0.3% in human pregnancy or lactation. Because Hyprogel 0.3% is applied topically to the eye and has negligible systemic absorption, the risk to a fetus or nursing infant is expected to be minimal; however, as a general precaution, Hyprogel 0.3% should be used during pregnancy and breastfeeding only if clearly needed, and a physician should be consulted before use in these situations.

• Hyprogel 0.3% is for topical ocular use only; it must not be injected or swallowed.
• Remove contact lenses before instilling Hyprogel 0.3%, unless the specific product is labeled as safe for use with contact lenses in place.
• Avoid letting the dropper tip touch the eye, eyelid, fingers, or any other surface, to prevent contamination of the product.
• Do not use the solution if it has changed color or become cloudy.
• Discontinue use and seek prompt medical evaluation if eye pain, changes in vision, or persistent redness or irritation occurs, or if the condition worsens or does not improve within 72 hours.
• Single-dose (preservative-free) containers are for one-time use only; discard any remaining solution after use and do not reuse.
• Do not share eye drop containers with other people, and avoid use in an eye that is infected, to reduce the risk of spreading infection.

Overdose with topical Hyprogel 0.3% is unlikely to cause serious harm because systemic absorption is negligible. Excessive or overly frequent instillation may cause temporary blurred vision, watering, or mild ocular irritation, which usually resolves once use is reduced to the recommended frequency.

If Hyprogel 0.3% is accidentally ingested in large amounts, or if severe eye irritation, pain, or an allergic reaction occurs after use, seek immediate medical attention or contact a poison control center / emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. Discard multi-dose bottles or tubes approximately 4 weeks after first opening. Single-dose (preservative-free) units are for one-time use only and must be discarded immediately after use.

Pediatric Use

Hyprogel 0.3% is commonly used in children for symptomatic relief of dry or irritated eyes; however, formal safety and efficacy studies specifically in pediatric populations are limited, and use in young children (especially infants) should be under medical guidance. See Pediatric Uses for further detail.

Geriatric Use

No special dosage adjustment is required in elderly patients. Hyprogel 0.3% is frequently used in this population, as age-related dry eye is common; general precautions (see Precautions and Warnings) apply equally.

Renal and Hepatic Impairment

Because Hyprogel 0.3% has negligible systemic absorption and is not systemically metabolized, no dose adjustment is required in patients with renal or hepatic impairment.

Contact Lens Wearers

Contact lenses should be removed before instilling Hyprogel 0.3% unless the specific product is labeled as safe for use with lenses in place.

Hyprogel 0.3% may be used on an as-needed basis for symptomatic relief of dry or irritated eyes, and can be used long-term for chronic dry eye conditions under general medical guidance. If symptoms do not improve, worsen, or persist beyond 72 hours of regular use, a physician or eye specialist should be consulted, since this may indicate an underlying condition requiring further evaluation rather than continued self-treatment.

Ophthalmic Lubricant; Artificial Tear Substitute; Ocular Demulcent

Hyprogel 0.3% acts as a viscosity-enhancing, film-forming demulcent on the surface of the eye. When instilled, it increases the viscosity of the tear film, helping it adhere to and remain on the corneal and conjunctival surfaces for longer than natural tears alone would. This prolonged contact reduces friction during blinking, limits evaporative water loss from the ocular surface, and provides a protective, lubricating coating over the cornea and conjunctiva. Hyprogel 0.3% does not have a pharmacologic or receptor-mediated mechanism of action; its effect is purely physical/mechanical, and it is not appreciably absorbed into systemic circulation.

Hyprogel 0.3% is widely used in children as an over-the-counter ocular lubricant for symptomatic relief of dry or irritated eyes, and it is generally regarded as having a favorable safety profile due to negligible systemic absorption. However, formal clinical studies establishing safety and efficacy specifically in pediatric populations, particularly infants and very young children, are limited, and the labeling position for many Hyprogel 0.3% products is that "safety and efficacy in pediatric patients have not been formally established" through controlled trials. Hyprogel 0.3% should be used in children under medical or parental supervision, using the correct instillation technique, and a pediatrician or eye specialist should be consulted before use in infants or if symptoms persist.